Seeking Alpha

RIGL
  Rigel Pharmaceuticals, Inc. - NASDAQ

8/21/2014, 9:58 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
RIGL vs. ETF Alternatives
Company Description
Rigel Pharmaceuticals Inc is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.